Timothy Hassall

Dr. Timothy Hassall is a Clinical Professor and Lead Clinical Investigator/Co-Director (SEC) at the Frazer Institute, part of the University of Queensland. His work focuses on pediatric oncology, particularly neuro-oncology and healthcare outcomes in childhood cancers. He has contributed to studies on quality of life, family functioning, and clinical management of pediatric brain tumors. His research also extends to epidemiology, clinical trials, and molecular diagnostics.

Research interests include pediatric brain tumors, longitudinal cohort studies, and the development of targeted therapies. He collaborates internationally on trials and guidelines for diffuse intrinsic pontine glioma and medulloblastoma. His work emphasizes translational research to improve patient care and survivorship.

Publications span epidemiological analyses, clinical trial outcomes, and molecular studies. He has been involved in studies assessing unmet needs in pediatric cancer families and the feasibility of physical activity interventions in survivorship.

His affiliation with the Frazer Institute underscores a commitment to translational research and bridging laboratory findings to clinical applications. He actively contributes to collaborative networks such as the Australian and New Zealand Children's Haematology/Oncology Group.